{"id":460,"date":"2022-06-15T09:07:00","date_gmt":"2022-06-15T16:07:00","guid":{"rendered":"https:\/\/caam.tech\/?p=460"},"modified":"2022-06-14T18:11:33","modified_gmt":"2022-06-15T01:11:33","slug":"mike-oshaughnessy-joins-caamtech-as-general-counsel-and-director-of-intellectual-property","status":"publish","type":"post","link":"https:\/\/caam.tech\/mike-oshaughnessy-joins-caamtech-as-general-counsel-and-director-of-intellectual-property\/","title":{"rendered":"Mike O\u2019Shaughnessy Joins CaamTech as General Counsel and Director of Intellectual Property"},"content":{"rendered":"\n<p><a href=\"https:\/\/caam.tech\/team\/mike-oshaughnessy\/\" data-type=\"page\" data-id=\"451\">Michael (Mike) O\u2019Shaughnessy<\/a> has joined CaaMTech as the company\u2019s Director of Intellectual Property. O\u2019Shaughnessy joins CaaMTech with more than two decades of experience in the life sciences and pharmaceutical industries, and expertise in the licensing of intellectual property.\u00a0 As the company\u2019s Director of Intellectual Property, Mike will manage CaaMTech\u2019s vast intellectual property portfolio, with over two hundred pending patent applications and issued patents protecting CaaMTech\u2019s unmatched library of novel compounds and formulations.<\/p>\n\n\n\n<p>Mike has served as an attorney and advisor to businesses in the life sciences and pharmaceutical industries for over 20 years, including Wyeth, Novartis, AbbVie, and Amgen.\u00a0 He negotiated high-value asset sales, acquisitions, and licenses, and litigated complex intellectual property disputes throughout the U.S. District Courts, International Trade Commission, and the Federal Circuit as a partner at some of the world\u2019s top law firms including Baker Botts, McDermott Will &amp; Emery, and Finnegan.\u00a0 Mike has extensive experience developing strategic partnerships and collaborations, managing and enforcing intellectual property portfolios, and navigating federal regulatory pathways.<\/p>\n\n\n\n<p>\u201cMike brings exactly the expertise that we need right now,\u201d said CaaMTech CEO, <a href=\"https:\/\/caam.tech\/team\/andrew-chadeayne\/\" data-type=\"page\" data-id=\"151\">Andrew Chadeayne<\/a>. \u201cAfter six years of mostly internal development, I am eager to expand our capabilities through collaborations.\u201d<\/p>\n\n\n\n<p>As CaaMTech\u2019s Director of Intellectual Property, O\u2019Shaughnessy will manage the psychedelic industry\u2019s foundational intellectual property portfolio.&nbsp; CaaMTech\u2019s unique focus on fundamental science has resulted in multiple pioneering innovations that support numerous areas of commercial development.&nbsp; In managing CaaMTech\u2019s IP department, O\u2019Shaughnessy will focus on advancing the company\u2019s technology towards commercial development through strategic partnerships and collaborations.<\/p>\n\n\n\n<p>\u201cI have been extremely fortunate to have worked with some of the best professionals throughout the pharmaceutical world.&nbsp; I have helped clients develop innovative portfolios, and commercialize successful products that benefit millions of patients around the world.\u201d said Mike O\u2019Shaughnessy, CaaMTech\u2019s newly appointed Director of Intellectual Property.&nbsp; \u201cBut nothing has been as exciting as this opportunity to join such a talented and innovative team at CaaMTech, where we will truly break new ground together, and serve patients in desperate need for new and effective technologies.&nbsp; We look forward to collaborating with partners throughout the industry to change the foundation of care.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p class=\"excerpt\">O\u2019Shaughnessy brings decades of experience in intellectual property strategy, collaborations, and development within the life sciences and pharmaceutical industries<\/p>\n","protected":false},"author":5,"featured_media":463,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/posts\/460"}],"collection":[{"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/comments?post=460"}],"version-history":[{"count":2,"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/posts\/460\/revisions"}],"predecessor-version":[{"id":464,"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/posts\/460\/revisions\/464"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/media\/463"}],"wp:attachment":[{"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/media?parent=460"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/categories?post=460"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/tags?post=460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}